Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
16 December 2003 | Volume 139 Issue 12 | Pages 979-986
Background: The belief that chest pain relief with nitroglycerin indicates the presence of active coronary artery disease is common. However, this hypothesis has not been tested.
Objective: To define the diagnostic and prognostic value of chest pain relief with nitroglycerin.
Design: Prospective observational cohort study.
Setting: Urban community teaching hospital.
Patients: 459 consecutive patients with chest pain admitted through the emergency department who received nitroglycerin from emergency services personnel or an emergency department nurse. Follow-up was obtained by telephone contact at 4 months.
Measurements: Chest pain relief was defined as a decrease of at least 50% in patients' self-reported pain within 5 minutes of the initial dose of sublingual or spray nitroglycerin. Active coronary artery disease was defined as any elevated serum enzyme levels, coronary angiography demonstrating a 70% or greater stenosis, or a positive exercise test result.
Results: Nitroglycerin relieved chest pain in 39% of patients (181 of 459). In patients with active coronary artery disease as the likely cause of their chest pain, 35% (49 of 141) had chest pain relief with nitroglycerin. In contrast, in patients without active coronary artery disease, 41% (113 of 275) had chest pain relief (P > 0.2). Four-month clinical outcomes were similar in patients with or without chest pain relief with nitroglycerin (P > 0.2).
Conclusions: These data suggest that, in a general population admitted for chest pain, relief of pain after nitroglycerin treatment does not predict active coronary artery disease and should not be used to guide diagnosis.
Editors' Notes
Context
Contribution
Implications
–The Editors
Author and Article Information
From Johns Hopkins Bayview Medical Center, Baltimore, Maryland.
Acknowledgments: The authors thank Edward Bessman, MD, for administrative support; Johann Brandes, MD, for assistance with patient follow-up; and Angel Sampedro for assistance with data analysis.
Grant Support: By a National Heart, Lung and Blood Institute Training grant #T32-HLO7227-26 (Dr. Henrikson).
Potential Financial Conflicts of Interest: None disclosed.
Requests for Single Reprints: Nisha Chandra-Strobos, MD, Division of Cardiology, Johns Hopkins Bayview Medical Center, 4940 Eastern Avenue, Baltimore, MD 21224; e-mail, nchandra{at}jhmi.edu.
Current Author Addresses: Drs. Henrikson, Miles, and Meininger: Division of Cardiology, Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, MD 21205.
Dr. Howell: Divison of General Internal Medicine, Johns Hopkins Bayview Medical Center, 4940 Eastern Avenue, Baltimore, MD 21224.
Drs. Bush, Chandra-Strobos, and Ms. Friedlander: Division of Cardiology, Johns Hopkins Bayview Medical Center, 4940 Eastern Avenue, Baltimore, MD 21224.
Dr. Bushnell: Division of Emergency Medicine, University of Vermont, 111 Colchester Ave., Burlington, VT 05401.
Author Contributions: Conception and design: C.A. Henrikson, E.E. Howell, D.E. Bush, N. Chandra-Strobos.
Analysis and interpretation of the data: C.A. Henrikson, E.E. Howell, D.E. Bush, N. Chandra-Strobos.
Drafting of the article: C.A. Henrikson.
Critical revision of the article for important intellectual content: C.A. Henrikson, E.E. Howell, D.E. Bush, J.S. Miles, G.R. Meininger, T. Friedlander, A.C. Bushnell, N. Chandra-Strobos.
Final approval of the article: C.A. Henrikson, E.E. Howell, D.E. Bush, J.S. Miles, G.R. Meininger, T. Friedlander, A.C. Bushnell, N. Chandra-Strobos.
Provision of study materials or patients: E.E. Howell, A.C. Bushnell, N. Chandra-Strobos.
Statistical expertise: C.A. Henrikson, D.E. Bush.
Administrative, technical, or logistic support: N. Chandra-Strobos.
Collection and assembly of data: C.A. Henrikson, E.E. Howell, J.S. Miles, G.R. Meininger, T. Friedlander, A.C. Bushnell. ARTICLE
Chest Pain Relief by Nitroglycerin Does Not Predict Active Coronary Artery Disease
![]()
![]()
Related articles in Annals:
This article has been cited by other articles:
![]() |
S. E. Hofkamp, C. A. Henrikson, and S. T. Wegener An Interactive Model of Pain and Myocardial Ischemia Psychosom Med, September 1, 2007; 69(7): 632 - 639. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine J. Am. Coll. Cardiol., August 14, 2007; 50(7): e1 - e157. [Full Text] [PDF] |
||||
![]() |
J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine J. Am. Coll. Cardiol., August 14, 2007; 50(7): 652 - 726. [Full Text] [PDF] |
||||
![]() |
Part 5: Acute Coronary Syndromes Circulation, November 29, 2005; 112(22_suppl): III-55 - III-72. [Full Text] [PDF] |
||||
![]() |
C. J. Swap and J. T. Nagurney Value and Limitations of Chest Pain History in the Evaluation of Patients With Suspected Acute Coronary Syndromes JAMA, November 23, 2005; 294(20): 2623 - 2629. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Evans and B. M. Reilly Chest Pain Relief by Nitroglycerin Ann Intern Med, August 17, 2004; 141(4): 324 - 324. [Full Text] [PDF] |
||||
![]() |
"The Pain Was Relieved by Nitro": Helpful Information? Journal Watch Gastroenterology, March 2, 2004; 2004(302): 8 - 8. [Full Text] |
||||
![]() |
I. Malik JournalScan Heart, March 1, 2004; 90(3): 353 - 354. [Full Text] [PDF] |
||||
![]() |
Does Nitroglycerin Response Have Diagnostic Value in the ER? Journal Watch Cardiology, February 13, 2004; 2004(213): 1 - 1. [Full Text] |
||||
![]() |
Response to Nitroglycerin Does Not Predict an Ischemic Cause for Chest Pain Journal Watch Emergency Medicine, February 3, 2004; 2004(203): 1 - 1. [Full Text] |
||||
![]() |
"The Pain Was Relieved by Nitro": Helpful Information? Journal Watch (General), January 16, 2004; 2004(116): 1 - 1. [Full Text] |
||||
![]() |
R. J. Gibbons Nitroglycerin: Should We Still Ask? Ann Intern Med, December 16, 2003; 139(12): 1036 - 1037. [Full Text] [PDF] |
||||